Ashish Sangal
Good Samaritan Hospital Medical Center(US)Good Samaritan University Hospital(US)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Pancreatic and Hepatic Oncology Research, Lung Cancer Research Studies, Lung Cancer Diagnosis and Treatment
Most-Cited Works
- → Tumor Cell–Free DNA Copy Number Instability Predicts Therapeutic Response to Immunotherapy(2017)158 cited
- → Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART)(2021)151 cited
- → A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus)(2017)130 cited
- → Palbociclib in Patients With Non–Small-Cell Lung Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study(2020)67 cited
- → Liquid nitrogen spray cryotherapy for dysphagia palliation in patients with inoperable esophageal cancer(2018)53 cited
- → Evaluation and comparison of two commercially available targeted next-generation sequencing platforms to assist oncology decision making(2015)37 cited
- → 795 A multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART)(2020)14 cited
- → A prospective pilot study of genome-wide exome and transcriptome profiling in patients with small cell lung cancer progressing after first-line therapy(2017)12 cited
- → Palbociclib (P) in patients (pts) with non-small cell lung cancer (NSCLC) with CDKN2A alterations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.(2019)10 cited
- → Association of radiation dose intensity with overall survival in patients with distant metastases(2021)8 cited